Gout - Xconomy

by in

Entry	Author	Date	Location
AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting	Bruce V. Bigelow	04/23/12	San Diego
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare	Arlene Weintraub	05/20/11	New York
San Diego’s Ardea Biosciences Sees Potential for Gout Drug in Combination Treatment	Denise Gellene	10/19/09	San Diego
Trius Approaches Next Stage in Drug Development, China Partnerships a Hot Topic at CalAsia, Lpath Headed to Critical Juncture, & More San Diego Life Sciences News	Bruce V. Bigelow	06/18/09	San Diego
Ardea Sees Early Signs of Effectiveness With Gout Drug	Luke Timmerman	06/11/09	San Diego
Ardea Biosciences Finds Early Results of Drug Candidate Equivalent to Existing Gout Treatment	Denise Gellene	04/20/09	San Diego
Amylin Braces to Battle Carl Icahn, Calit2′s Network for Institutional Innovation, Sangart Ponders Its Next Move, & More San Diego BizTech News	Bruce V. Bigelow	04/13/09	San Diego
Ardea Biosciences, in Moment of Serendipity, Discovers HIV Drug That May Work for Gout	Luke Timmerman	04/08/09	San Diego
Ardea Raises $30.6M in Stock Sale	Gregory T. Huang	12/19/08	San Diego
Page 1 of 1

Xconomy National